KB-0742
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KB-0742, covering 2025-02-17 to 2025-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC) [Phase 1, Phase 2]